Leading the Way in Oncology Insights
Resources highlighting oncology data trends and company announcements.
Articles and Press Releases
-
![Caris & MiBA Partner to Advance Oncology Care]()
Caris Life Sciences Collaborates with MiBA to Advance Oncology Education and Quality Care
IRVING, Texas & TAMPA, Florida, April 24, 2025 – Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced a strategic collaboration with MiBA, an innovative healthcare technology company to provide physician education and insights to accelerate research, identify and personalize treatment plans.
-
![MiBA Appoints Matt Hagan as VP of Marketing & Client Innovation]()
MiBA Appoints Matt Hagan as VP of Marketing & Client Innovation
TAMPA, Florida, March 7, 2025 – Meaningful Insights Biotech Analytics (MiBA) is pleased to announce the appointment of Matt Hagan as Vice President of Marketing and Client Innovation. With over 27 years of experience in biopharmaceutical marketing and commercial roles, Matt brings extensive industry knowledge and expertise to MiBA.
-
![]()
MiBA and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care
PALO ALTO, Calif., and TAMPA, Fla., December 20, 2024 — Guardant Health, Inc. (Nasdaq: GH) and Meaningful Insights Biotech Analytics (MiBA) today announced a unique partnership aimed at optimizing the use of biomarker testing and data analytics to advance precision medicine in patient care throughout the MiBA Network.
-
![]()
Joint Press Release: MiBA and NCODA Partner to Launch Oncology Insights Program
Tampa, FL & Cazenovia, NY October 22, 2024 – Meaningful Insights Biotech Analytics, LLC (MiBA) and the National Community Oncology Dispensing Association (NCODA) are pleased to announce their partnership on the launch of the Oncology Insights Program (OIP), an innovative and educational initiative powered by prescriber data.
-
![]()
Introducing MiBA and How We Drive Informed Decision Making to Improve Patient Outcomes
At MiBA, we never lose sight of what matters most - the patient. We're a revolutionary healthcare technology company redefining the landscape of patient care and medical research. Our mission is to advance healthcare quality through actionable, data-centered intelligence, bridging gaps and empowering better outcomes for all stakeholders in the healthcare ecosystem.
-
![MiBA + Foundation Medicine]()
MiBA and Foundation Medicine Partner to Advance Genomic Profiling Utilization in Cancer Care
Meaningful Insights Biotech Analytics (MiBA), announced a unique partnership with Foundation Medicine, Inc. to expand awareness of and education on comprehensive genomic profiling (CGP) in the community oncology setting.
-
![]()
MiBA: Pioneering Data-Driven Oncology Insights for a Healthier Tomorrow
Meaningful Insights Biotech Analytics (MiBA), a trailblazing healthcare technology company, officially announces its launch, offering innovative data analytics solutions to transform oncology care and research.
-
![]()
Cellectar Biosciences Partners with MiBA
Partnership to Provide Key Data on WM Treatment Landscape and Community Clinic Access to Support Iopofosine I 131 Commercialization Strategy
Together, we can turn data into breakthroughs.
Contact us for a personalized demonstration and discover how our platform can revolutionize your approach to cancer research and patient care.